Article
FGFR3 – a Central Player in Bladder Cancer Pathogenesis?
2020-09-09
Abstract excerpt
The identification of mutations in FGFR3 in bladder tumors in 1999 led to major interest in this receptor and during the subsequent 20 years much has been learnt about the mutational profiles found in bladder cancer, the phenotypes associated with these and the potential of this mutated protein as a target for therapy. Based on mutational and expression data, it is estimated that >80% of non-muscle-invasive bladde...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fe7a459c-eb00-5781-b1e0-fb677787e427
- DOI
- 10.3233/blc-200373